1 / 8

Epilepsy Therapeutics Market 2019 in APAC Region

Single User License: US $2500; Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=322414.

scottlisa57
Download Presentation

Epilepsy Therapeutics Market 2019 in APAC Region

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epilepsy Therapeutics Market in the APAC Region 2015-2019 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: December 2014 Single User PDF: US$ 2500 Corporate User PDF: US$ 3500 © ReportsnReports.com / Contact sales@reportsandreports.com

  2. Epilepsy Therapeutics Market in the APAC Region 2015-2019 Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as in the majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures. Occurrence of two or more unprovoked seizures is an important criterion to diagnose a person as being epileptic. Analysts forecast the Epilepsy Therapeutics market in the APAC to grow at a CAGR of 5.78 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Epilepsy Therapeutics market in the APAC for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of anti-epileptic drugs used for the treatment of the symptoms of epilepsy in APAC. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  3. Epilepsy Therapeutics Market in the APAC Region 2015-2019 The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market in the region. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Single User License: US $2500; Inquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=322414. Epilepsy Therapeutics Market in the APAC 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Countries Australia China India Japan Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  4. Epilepsy Therapeutics Market in the APAC Region 2015-2019 Key Vendors Eisai, GlaxoSmithKline, Pfizer, UCB Other Prominent Vendors Abbvie, Acorda Therapeutics, Dainippon Sumitomo Pharma, F. Hoffmann-La Roche, H. Lundbeck, Janssen Pharmaceuticals, Marinus Pharmaceuticals, Meda AB, Novartis, Sage Therapeutics, Shire, Sunovion Pharmaceuticals, Supernus Pharmaceuticals, Upsher-Smith Laboratories, Valeant Pharmaceuticals Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=322414. Market Driver Unmet Medical Need Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  5. Epilepsy Therapeutics Market in the APAC Region 2015-2019 Market Challenge Generic Erosion Market Trend Reformulation of Marketed Drugs Key Questions Answered in this Report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  6. Epilepsy Therapeutics Market in the APAC Region 2015-2019 List of Exhibits Exhibit 1: Market Research MethodologyExhibit 2: Incidence and Prevalence of Epilepsy by WHOExhibit 3: Treatment Statistics for EpilepsyExhibit 4: Prevalence of Epilepsy in ChinaExhibit 5: NIH Funding for Epilepsy (US$ million) FY2011-FY2015Exhibit 6: Epilepsy Therapeutics market in APAC 2014-2019 (US$ million)Exhibit 7: Epilepsy Therapeutics Market in APAC Segmentation by Generation of DrugsExhibit 8: Market Share of APAC in Global Epilepsy MarketExhibit 9: Epilepsy Therapeutics Market in APAC by Country 2014Exhibit 10: Epilepsy Therapeutics market in APAC by Country 2019Exhibit 11: Epilepsy Therapeutics Market in APAC 2014-2019 (US$ million)Exhibit 12: Epilepsy Therapeutics Market in APAC 2014-2019Exhibit 13: Epilepsy Market in Japan 2014-2019 (US$ million)Exhibit 14: Epilepsy Market in Australia 2014-2019 (US$ million)Exhibit 15: Epilepsy Market in China 2014-2019 (US$ million)Exhibit 16: Epilepsy Market in India 2014-2019 (US$ million)Exhibit 17: Key Leading Countries in the Epilepsy Therapeutics market in APAC 2014Exhibit 18: Impact of Loss of Exclusivity for Lyrica in Canadian market (US$ million) Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  7. Epilepsy Therapeutics Market in the APAC Region 2015-2019 Exhibit 19: GlaxoSmithKline: Anti-epileptic Drug Portfolio in APACExhibit 20: Lamictal Revenue 2011-2014 (US$ million) Inquiry Before Buying @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=322414. Exhibit 21: Lamictal Sales Segmentation by Geography 2014Exhibit 22: Eisai: Anti-epileptic Drug Portfolio in APACExhibit 23: Fycompa: Pipeline StatusExhibit 24: Inovelon: Pipeline StatusExhibit 25: UCB: Anti-epileptic Drug Portfolio in APACExhibit 26: Keppra Sales 2010-2014 (US$ million)Exhibit 27: Keppra Sales by Geography 2014Exhibit 28: Vimpat Sales by 2009-2014 (US$ million)Exhibit 29: Vimpat Sales by Geography 2014Exhibit 30: Vimpat: Pipeline StatusExhibit 31: Lyrica Revenue 2011-2014 (US$ million)Exhibit 32: Lyrica Revenue by Geography 2014Exhibit 33: Eisai: Product Segmentation by Revenue 2014 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

  8. Epilepsy Therapeutics Market in the APAC Region 2015-2019 Exhibit 34: Eisai: Product Segmentation by Revenue 2013 and 2014 (US$ million)Exhibit 35: Eisai: Geographical Segmentation by Revenue 2014Exhibit 36: GlaxoSmithKline: Business Segmentation 2014Exhibit 37: GlaxoSmithKline: Business Segmentation by Revenue 2013 and 2014 (US$ billion)Exhibit 38: GlaxoSmithKline: Sales by Geography 2014Exhibit 39: GlaxoSmithKline: Pipeline Products 2014Exhibit 40: Pfizer: Business Segmentation by Revenue 2014Exhibit 41: Pfizer: Business Segmentation by Revenue 2013 and 2014Exhibit 42: Pfizer: Geographical Segmentation by Revenue 2014Exhibit 43: UCB: Product Segmentation by Revenue 2014Exhibit 44: UCB: Product Segmentation by Revenue 2013 and 2014 (US$ million)Exhibit 45: UCB: Geographical Segmentation by Revenue 2014 Explore Report on Pharmaceuticals Market. Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Epilepsy Therapeutics Market in the APAC Region 2015-2019” report OR for any other market research and intelligence needs you may have for your business. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

More Related